A
Azitra, Inc. (AZTR)
ASE – Real Time Price. Currency in USD
0.24
+0.00 (1.69%)
At close: Mar 27, 2026, 4:00 PM EDT
0.24
+0.00 (1.25%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
ASE – Real Time Price. Currency in USD
0.24
+0.00 (1.69%)
At close: Mar 27, 2026, 4:00 PM EDT
0.24
+0.00 (1.25%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
| Name | Position |
|---|---|
| Dr. Travis M. Whitfill M.P.H., Ph.D. | Co-Founder, COO, Secretary & Director |
| Mr. Francisco D. Salva | President, CEO & Director |
| Mr. Norman Staskey | CFO & Treasurer |
| Date | Type | Document |
|---|---|---|
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-03-05 | 8-K | form8-k.htm |
| 2026-01-30 | S-8 | forms-8.htm |
| 2026-01-02 | DEF 14A | formdef14a.htm |
| 2025-12-23 | PRE 14A | formpre14a.htm |
| 2025-12-17 | 8-K | form8-k.htm |
| 2025-12-10 | S-1 | forms-1.htm |
| 2025-12-01 | S-8 | forms-8.htm |
| 2025-11-25 | 8-K | form8-k.htm |
| 2025-11-12 | 8-K | aztr-20251112.htm |